- Home
- CNSP vs CTNT Comparison
CNSP vs CTNT Comparison
Compare CNSP & CTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- CTNT
- Stock Information
- Founded
- CNSP 2017
- CTNT 2016
- Country
- CNSP United States
- CTNT United States
- Employees
- CNSP N/A
- CTNT N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- CTNT
- Sector
- CNSP Health Care
- CTNT
- Exchange
- CNSP Nasdaq
- CTNT Nasdaq
- Market Cap
- CNSP 5.6M
- CTNT 6.5M
- IPO Year
- CNSP 2019
- CTNT 2023
- Fundamental
- Price
- CNSP $1.25
- CTNT $1.37
- Analyst Decision
- CNSP Hold
- CTNT Hold
- Analyst Count
- CNSP 1
- CTNT 1
- Target Price
- CNSP N/A
- CTNT N/A
- AVG Volume (30 Days)
- CNSP 332.7K
- CTNT 17.5K
- Earning Date
- CNSP 05-14-2025
- CTNT 05-12-2025
- Dividend Yield
- CNSP N/A
- CTNT N/A
- EPS Growth
- CNSP N/A
- CTNT N/A
- EPS
- CNSP N/A
- CTNT N/A
- Revenue
- CNSP N/A
- CTNT $455,805.00
- Revenue This Year
- CNSP N/A
- CTNT $258.05
- Revenue Next Year
- CNSP N/A
- CTNT N/A
- P/E Ratio
- CNSP N/A
- CTNT N/A
- Revenue Growth
- CNSP N/A
- CTNT N/A
- 52 Week Low
- CNSP $1.21
- CTNT $1.25
- 52 Week High
- CNSP $800.00
- CTNT $236.16
- Technical
- Relative Strength Index (RSI)
- CNSP 30.28
- CTNT 27.83
- Support Level
- CNSP $1.28
- CTNT $1.25
- Resistance Level
- CNSP $1.46
- CTNT $1.60
- Average True Range (ATR)
- CNSP 0.38
- CTNT 0.16
- MACD
- CNSP -0.12
- CTNT -0.01
- Stochastic Oscillator
- CNSP 1.18
- CTNT 17.70
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a supplier of parallel-import vehicles sourced in the U.S. to be sold in the China market. The parallel-import vehicles refer to those purchased by dealers directly from overseas markets and imported for sale through channels other than brand manufacturers' official distribution systems. The company purchases automobiles, luxury brands such as Mercedes, BMW, Porsche, Lexus, and Bentley, from the U.S. market and resells them to customers, including both U.S. and PRC parallel-import car dealers. The company derives profits from the price difference between buying and selling prices for parallel-import vehicles.